These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 11960989)
1. Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia. Valentini G; Chiarelli LR; Fortin R; Dolzan M; Galizzi A; Abraham DJ; Wang C; Bianchi P; Zanella A; Mattevi A J Biol Chem; 2002 Jun; 277(26):23807-14. PubMed ID: 11960989 [TBL] [Abstract][Full Text] [Related]
2. Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia. Wang C; Chiarelli LR; Bianchi P; Abraham DJ; Galizzi A; Mattevi A; Zanella A; Valentini G Blood; 2001 Nov; 98(10):3113-20. PubMed ID: 11698298 [TBL] [Abstract][Full Text] [Related]
3. Erythrocyte pyruvate kinase- and glucose phosphate isomerase deficiency: perturbation of glycolysis by structural defects and functional alterations of defective enzymes and its relation to the clinical severity of chronic hemolytic anemia. Lakomek M; Winkler H Biophys Chem; 1997 Jun; 66(2-3):269-84. PubMed ID: 9362562 [TBL] [Abstract][Full Text] [Related]
4. [From gene to disease; hereditary non-spherocytic hemolytic anemia caused by pyruvate kinase deficiency]. de Vooght KM; van Wijk R; Nieuwenhuis HK; Ploos van Amstel JK; Rijksen G; van Solinge WW Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1828-31. PubMed ID: 12382367 [TBL] [Abstract][Full Text] [Related]
5. Erythrocyte adenylate kinase deficiency: characterization of recombinant mutant forms and relationship with nonspherocytic hemolytic anemia. Abrusci P; Chiarelli LR; Galizzi A; Fermo E; Bianchi P; Zanella A; Valentini G Exp Hematol; 2007 Aug; 35(8):1182-9. PubMed ID: 17662886 [TBL] [Abstract][Full Text] [Related]
6. Molecular modelling of human red blood cell pyruvate kinase: structural implications of a novel G1091 to a mutation causing severe nonspherocytic hemolytic anemia. van Solinge WW; Kraaijenhagen RJ; Rijksen G; van Wijk R; Stoffer BB; Gajhede M; Nielsen FC Blood; 1997 Dec; 90(12):4987-95. PubMed ID: 9389718 [TBL] [Abstract][Full Text] [Related]
7. Mining for allosteric information: natural mutations and positional sequence conservation in pyruvate kinase. Pendergrass DC; Williams R; Blair JB; Fenton AW IUBMB Life; 2006 Jan; 58(1):31-8. PubMed ID: 16540430 [TBL] [Abstract][Full Text] [Related]
9. Hereditary erythrocyte pyruvate-kinase (PK) deficiency and chronic hemolytic anemia: clinical, genetic and molecular studies in six new Spanish patients. Vives-Corrons JL; Marie J; Pujades MA; Kahn A Hum Genet; 1980; 53(3):401-8. PubMed ID: 7372343 [TBL] [Abstract][Full Text] [Related]
10. Spectrum of novel mutations in the human PKLR gene in pyruvate kinase-deficient Indian patients with heterogeneous clinical phenotypes. Kedar P; Hamada T; Warang P; Nadkarni A; Shimizu K; Fujji H; Ghosh K; Kanno H; Colah R Clin Genet; 2009 Feb; 75(2):157-62. PubMed ID: 18759866 [TBL] [Abstract][Full Text] [Related]
11. Life-threatening nonspherocytic hemolytic anemia in a patient with a null mutation in the PKLR gene and no compensatory PKM gene expression. Diez A; Gilsanz F; Martinez J; Pérez-Benavente S; Meza NW; Bautista JM Blood; 2005 Sep; 106(5):1851-6. PubMed ID: 15870173 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis of pyruvate kinase deficiency among Tunisians: description of new mutations affecting coding and noncoding regions in the PKLR gene. Jaouani M; Manco L; Kalai M; Chaouch L; Douzi K; Silva A; Macedo S; Darragi I; Boudriga I; Chaouachi D; Fitouri Z; Van Wijk R; Ribeiro ML; Abbes S Int J Lab Hematol; 2017 Apr; 39(2):223-231. PubMed ID: 28133914 [TBL] [Abstract][Full Text] [Related]
14. Molecular basis of red cell enzymopathies associated with hereditary nonspherocytic hemolytic anemia. Miwa S Haematologia (Budap); 1989; 22(4):215-31. PubMed ID: 2560452 [TBL] [Abstract][Full Text] [Related]
15. Hydrops fetalis associated with erythrocyte pyruvate kinase deficiency. Ferreira P; Morais L; Costa R; Resende C; Dias CP; Araújo F; Costa E; Barbot J; Vilarinho A Eur J Pediatr; 2000 Jul; 159(7):481-2. PubMed ID: 10923218 [TBL] [Abstract][Full Text] [Related]
16. Molecular and clinical heterogeneity in pyruvate kinase deficiency in India. Warang P; Kedar P; Ghosh K; Colah R Blood Cells Mol Dis; 2013 Oct; 51(3):133-7. PubMed ID: 23770304 [TBL] [Abstract][Full Text] [Related]
17. Eight novel mutations and consequences on mRNA and protein level in pyruvate kinase-deficient patients with nonspherocytic hemolytic anemia. Kugler W; Willaschek C; Holtz C; Ohlenbusch A; Laspe P; Krügener R; Muirhead H; Schröter W; Lakomek M Hum Mutat; 2000; 15(3):261-72. PubMed ID: 10679942 [TBL] [Abstract][Full Text] [Related]
18. [Erythrocyte pyruvate kinase in healthy subjects and in nonspherocytic hemolytic pyruvate-kinase deficiency anemia]. Wiesmann U; Tönz O; Richterich R; Verger P Klin Wochenschr; 1965 Dec; 43(24):1311-8. PubMed ID: 5873393 [No Abstract] [Full Text] [Related]
19. Red cell pyruvate kinase deficiency: from genetics to clinical manifestations. Zanella A; Bianchi P Baillieres Best Pract Res Clin Haematol; 2000 Mar; 13(1):57-81. PubMed ID: 10916678 [TBL] [Abstract][Full Text] [Related]
20. Biphasic reaction kinetics in an anomalous isozyme of erythrocyte pyruvate kinase. Paglia DE; Konrad PN; Wolff JA; Valentine WN Clin Chim Acta; 1976 Dec; 73(3):395-405. PubMed ID: 1000857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]